Menu

Michael McCaughan (left) and Tom O’Donnell(right) speak during a Feb. 11 “Washington Update” keynote address at the 340B Coalition Winter Conference.

Michael McCaughan (left) and Tom O’Donnell (right) speak during a Feb. 11 “Washington Update” keynote address at the 340B Coalition Winter Conference in San Diego.

Major Congressional 340B Action Unlikely in 2026, but Trump Administration Policies Could Still Affect Program, Health Policy Experts Say

February 12, 2026 William Newton 340B Report Views

Major federal 340B legislation is unlikely to move through Congress in 2026—but a series of White House drug pricing initiatives [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton

PhRMA Exec Slams 340B Hospital Markups at Congressional Hearing, Lawmakers Pass on Addressing Program

The Rebate Pause Bought Time – Not Certainty